Benzinga | Feb 24, 2021 07:16AM EST

Ionis Pharmaceuticals Q4 Adj. Net Income $103M vs $296M In Same Qtr. Last Year, Sales $290.00M Beat $274.48M Estimate

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly sales of $290.00 million which beat the analyst consensus estimate of $274.48 million by 5.65 percent. This is a 41.30 percent decrease over sales of $494.00 million the same period last year.